Yew Bio-Pharm Group, Inc. (OTCMKTS:YEWB) Files An 8-K Regulation FD Disclosure

Yew Bio-Pharm Group, Inc. (OTCMKTS:YEWB) Files An 8-K Regulation FD Disclosure

Story continues below

Item 7.01Regulation FD Disclosure

On June 9, 2017, the Company issued a press release announcing
the launch of its new e-commerce website. A copy of the press
release is filed as Exhibit 99.1 to this Current Report on Form
8-K and is incorporated herein by reference.

This disclosure does not constitute an offer to sell, or the
solicitation to buy, any such security.

Item9.01 Financial Statements and Exhibits.

Exhibit

Number

Description
99.1 Press release, dated June 9, 2017 of Yew Bio-Pharm Group,
Inc.

(s)


About Yew Bio-Pharm Group, Inc. (OTCMKTS:YEWB)

Yew Bio-Pharm Group, Inc. is a grower and seller of yew trees and manufacturer of products made from yew trees in China. The Company operates through five segments: traditional Chinese medicine (TCM) raw materials, which is engaged in the production and sale of raw materials used for medicinal application in the pharmaceutical industry; yew trees, which is engaged in the cultivation and sale of yew seedlings, yew trees and potted yew trees; handicrafts, which is engaged in the manufacture and sale of furniture and handicrafts made of yew timber; wood ear mushroom, which includes the sale of wood ear mushroom, and others, which includes the sale of yew candles and pine needle extracts. It is engaged in processing and selling yew raw materials used in the manufacture of TCM; growing and selling yew tree seedlings and mature trees, including potted miniature yew trees; manufacturing and selling furniture and handicrafts made of yew tree timber, and selling agricultural products.

An ad to help with our costs